Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016
-
Upload
national-osteoporosis-society -
Category
Healthcare
-
view
54 -
download
1
Transcript of Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016
![Page 1: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/1.jpg)
What are the properties of the perfect therapy for
osteoporosis?Professor Jon Tobias
Musculoskeletal Research Unit Southmead Hospital
![Page 2: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/2.jpg)
Disclosure statementSpeaker fees from Amgen, Lilly and UCB
![Page 3: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/3.jpg)
Summary• Bone quality changes in osteoporosis• Effects of drug treatment on bone quality• Clinical implications of therapeutic effects on bone
quality
![Page 4: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/4.jpg)
The Perfect Therapy for Osteoporosis• Easy to administer
• Oral as opposed to parenteral• Extended interval dosing
• Low cost• Safe and well tolerated• Persistent benefit on stopping
![Page 5: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/5.jpg)
The Perfect Therapy for Osteoporosis• Easy to administer
• Oral as opposed to parenteral• Extended interval dosing
• Low cost• Safe and well tolerated• Persistent benefit on stopping• OPTIMAL EFFICACY
![Page 6: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/6.jpg)
Assessing efficacy of anti-osteoporotic therapy• Clinical end-points
• Vertebral and non vertebral fracture risk• Intermediate end-points
• Bone mineral density• Bone turnover markers
• Evaluating bone strength• Measurement of individual determinants of ‘bone quality’
e.g histomorphometry on iliac crest bone biopsies, high resolution imaging (HR-pQCT)
![Page 7: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/7.jpg)
Use of HR-pQCT to examine structural changes of cortical and trabecular bone with osteoporosis therapy
![Page 8: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/8.jpg)
Summary• Bone quality changes in osteoporosis• Effects of drug treatment on bone quality• Clinical implications of therapeutic effects on bone
quality
![Page 9: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/9.jpg)
Determinants of Bone QualityMacroarchitecture/Geometry Microarchitecture
Material properties
Periosteal circumference Hip axis length Trabecular bone structure Cortical bone structure
Skeletal mineralisation
![Page 10: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/10.jpg)
Determinants of Bone QualityMacroarchitecture/Geometry Microarchitecture
Material properties
Periosteal circumference Hip axis length Trabecular bone structure Cortical bone structure
Skeletal mineralisation
![Page 11: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/11.jpg)
Osteoporosis and Trabecular Bone
Increased activation frequency Increased erosion depth. Reduced trabecular thickness. Trabecular perforation and removal
Normal Osteoporosis
![Page 12: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/12.jpg)
Structural changes in trabecular bone associated with osteoporosis
Normal Osteoporotic
Images courtesy of Alan Boyde
![Page 13: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/13.jpg)
Osteoporosis and Cortical Bone Increase in size and number of Haversian canals
leading to greater cortical porosity Endosteal expansion leading to cortical thinning
OsteoporosisNormal
Haversian canalPeriosteum
Endosteum
![Page 14: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/14.jpg)
Increased age-related intra-cortical remodelling and porosity of the inner cortex(female post-mortem samples)
(A) Micrograph of a specimen from a 29-year-old woman. Pores are regular in shape and evenly distributed in the cortex. (B) Micrograph of a specimen from a 67-year-old woman. Pores are large, irregularly shaped, and have coalesced in cortex adjacent to the marrow producing cortical remnants.
(C) Micrograph of a specimen from a 90-year-old woman. Most of the cortex is trabecularised by large and coalesced pores. R Zebaze et al, Lancet 2010 375: 1672-3
![Page 15: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/15.jpg)
Summary• Bone quality changes in osteoporosis• Effects of drug treatment on bone quality• Clinical implications of therapeutic effects on bone
quality
![Page 16: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/16.jpg)
Treating Osteoporosis
Overactive bone resorption Underactive bone formation
![Page 17: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/17.jpg)
Treating Osteoporosis
Overactive bone resorption Underactive bone formation
Anti-resorptive agenteg zoledronate
Anabolic agenteg teriparatide
![Page 18: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/18.jpg)
Summary• Bone quality changes in osteoporosis• Effects of anti-resorptives on bone quality
• Bisphosphonates• Oral eg Alendronic acid• IV eg Zoledronate
• Denosumab
![Page 19: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/19.jpg)
Preservation of trabecular architecture after 3 years treatment with annual IV Zoledronate as assessed on iliac crest bone biopsies
R Recker et al Journal of Bone and Mineral Research Volume 23, Issue 1 pages 6-16, 10 SEP 2007
Whole Biopsy Thick Section Thin Section
![Page 20: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/20.jpg)
Differing effects of PTH 1–34, PTH 1–84, and zoledronate on cortical microarchitecture using HR‐pQCT
S Hansen et al JBMR Volume 28, Issue 4, pages 736-745, 18 MAR 2013
![Page 21: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/21.jpg)
Increased cortical thickness with anti-resorptive agents due reversal of endosteal resorption?
![Page 22: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/22.jpg)
*, P < .05 vs baseline; **, P < .05 vs 12-months for 12- to 24-month change; a, P < .05 vs TPTD alone; b, P < .05 vs DMAB alone.
J. N. Tsai et al The Journal of Clinical Endocrinology & Metabolism 2016, 101, 2023-2030.
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture (DATA-HRpQCT study)
![Page 23: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/23.jpg)
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
R Zebaze JBMR 19 MAY 2016 DOI: 10.1002/jbmr.2855
Cortical porosity from low resolution hip CT scans using Straxcorp software
![Page 24: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/24.jpg)
BMD gains are more sustained with denosumab versus zoledronate: role of cortical bone changes?
Horizon Extension (zoledronate)
1 2 3 4 50 6
†
18.4%†
†
**
*
*
*
*
†
†
† 13.7%
7 8–2
02468
10121416
2018
Lumbar Spine
–2
0
2
4
6
8
10
Total Hip
Perc
enta
ge C
hang
e Fr
om B
asel
ine
Study Year Study Year
FREEDOM EXTENSION FREEDOM EXTENSION
1962 14572086 1567
118‡
139‡
120‡
140‡
20222149
19972124
20062132
18952017
20052111
14881589
119‡
139‡
122‡
140‡
120‡
140‡
122‡
141‡
20292148
19242041
* **
1 2 3 4 50 6
**
**
*
8.3%†
††
†
†
† 4.9%
7 8
†
†
†
†
14631551
14231518
Long-term Denosumab Cross-over DenosumabPlacebo
FREEDOM extension (denosumab)
DM Black et al 2012 JBMR 27:243 Papapoulos S, et al. 2015 OI 26:2773
![Page 25: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/25.jpg)
Effects of osteoporotic treatments on bone quality
Effect on bone quality
Anti-resorptive
Trabecular architecture
Preserved
Cortical thickness Increased +
Cortical porosity Reduced
![Page 26: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/26.jpg)
Summary• Bone quality changes in osteoporosis• Effects of anti-resorptives on bone quality• Effects of anabolic agents on bone quality
• Teriparatide (PTH1-34)/PTH 1-84• Second generation anabolic agents
• Abaloparatide• Romosozumab
![Page 27: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/27.jpg)
3-D µCT images of iliac crest biopsies before and after 1-84 PTH treatment for 18 months
RR Recker et al 2009 Bone 44:113
Before After
![Page 28: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/28.jpg)
Differing effects of PTH 1–34, PTH 1–84, and zoledronate on cortical microarchitecture using HR‐pQCT
S Hansen et al JBMR Volume 28, Issue 4, pages 736-745
![Page 29: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/29.jpg)
Effect of teriparatide on cortical bone of the radius
JR Zanchetta et al 2003 JBMR 18:539
![Page 30: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/30.jpg)
Does periosteal apposition contribute to the increased cortical thickness after treatment with anabolic agents?
![Page 31: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/31.jpg)
Cross sectional moment of inertia (CSMI) is strongly dependent on overall bone size
Anti-resorptive agent Anabolic agent
Bone accumulation
![Page 32: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/32.jpg)
Effects of osteoporotic treatments on bone quality
Effect on bone quality
Anti-resorptive Anabolic(Teriparatide)
Trabecular architecture
Preserved Improved
Cortical thickness Increased + Increased ++
Cortical porosity Reduced Increased
![Page 33: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/33.jpg)
*, P < .05 vs baseline; **, P < .05 vs 12-months for 12- to 24-month change; a, P < .05 vs TPTD alone; b, P < .05 vs DMAB alone.
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture (DATA-HRpQCT study)
J. N. Tsai et al The Journal of Clinical Endocrinology & Metabolism 2016, 101, 2023-2030.
![Page 34: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/34.jpg)
Effects of osteoporotic treatments on bone quality
Effect on bone quality
Anti-resorptive Anabolic(Teriparatide)
Combined(Denosumab + teriparatide)
Trabecular architecture
Preserved Improved Improved
Cortical thickness Increased + Increased ++ Increased ++
Cortical porosity Reduced Increased Reduced
![Page 35: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/35.jpg)
Summary• Bone quality changes in osteoporosis• Effects of anti-resorptives on bone quality• Effects of anabolic agents on bone quality
• Teriparatide (PTH1-34)/PTH 1-84• Second generation anabolic agents
• Abaloparatide• Romosozumab
![Page 36: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/36.jpg)
ACTIVE: Change in bone turnover markers following treatment with Teriparatide or Abaloparatide
Miller PD et al JAMA. 2016;316(7):722-733. doi:10.1001
![Page 37: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/37.jpg)
ACTIVE: Change in BMD following treatment with Teriparatide or Abaloparatide
Miller PD et al JAMA. 2016;316(7):722-733. doi:10.1001
![Page 38: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/38.jpg)
Change in Bone-Turnover Markers with Alendronate, Teriparatide and Romosozumab
McClung MR et al. N Engl J Med 2014;370:412-420.
![Page 39: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/39.jpg)
Change in BMD with Alendronate, Teriparatide and Romosozumab
McClung MR et al. N Engl J Med 2014;370:412-420.
![Page 40: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/40.jpg)
Effects of 12 months Romosozumab and Teriparatide at the Spine and Hip by QCT
H Genant et al Journal of Bone and Mineral Research 20 SEP 2016 DOI: 10.1002
Spine
Hip
![Page 41: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/41.jpg)
Effects of osteoporotic treatments on bone quality
Effect on bone quality
Anti-resorptive Anabolic(Teriparatide)
Combined(Denosumab + teriparatide)
Second generation anabolic
Trabecular architecture
Preserved Improved Improved Improved
Cortical thickness Increased + Increased ++ Increased ++ Increased +++
Cortical porosity Reduced Increased Reduced Unaffected or reduced ?
![Page 42: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/42.jpg)
Summary• Bone quality changes in osteoporosis• Effects of drug treatment on bone quality• Clinical implications of therapeutic effects on bone
quality
![Page 43: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/43.jpg)
Summary• Bone quality changes in osteoporosis• Effects of drug treatment on bone quality• Clinical implications of therapeutic effects on bone
quality• Do therapeutic agents influence bone quality at critical
sites for fracture?• Do effects of different therapeutic agents on bone quality
translate into reduced fracture risk?
![Page 44: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/44.jpg)
Cortical thickness maps from hip CT scans before and 24 months after Teriparatide
K Poole et al PloS One 2011 6: e16190
Baseline:
Post-teriparatide:
Statistical change map:
C = subcapital superior femoral neck
![Page 45: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/45.jpg)
Fracture risk ratio after treatment with anabolic versus anti-resorptive agentsClass Drug Trial
(duration in months)
Vertebral fractures
Anti-resorptive Alendronate FIT (36) 0.53
Zoledronate HORIZON (36) 0.30
Denosumab FREEDOM (36) 0.32
Anabolic Teriparatide ACTIVE (18) 0.20
Abaloparatide ACTIVE (18) 0.14
Romosozumab FRAME (12) 0.27*
*F Cosman et al, NEJM 2016, In Press
![Page 46: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/46.jpg)
Fracture risk ratio after treatment with anabolic versus anti-resorptive agentsClass Drug Trial
(duration in months)
Vertebral fractures
Non-vertebral fractures
Anti-resorptive Alendronate FIT (36) 0.53 0.70
Zoledronate HORIZON (36) 0.30 0.67
Denosumab FREEDOM (36) 0.32 0.80
Anabolic Teriparatide ACTIVE (18) 0.20 0.70
Abaloparatide ACTIVE (18) 0.14 0.57
Romosozumab FRAME (12) 0.27 0.75
![Page 47: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/47.jpg)
Conclusions• Optimal treatments for osteoporosis enhance bone
quality by improving trabecular architecture, increasing cortical thickness and overall bone size, and reducing cortical porosity
• This may require a combination of anabolic and anti-resorptive actions, which may or may not be possible using a single agent alone
• Anabolic agents may have improved skeletal safety compared to anti-resorptive drugs, given atypical femoral fractures and other complications arise from over-suppression of bone resorption
![Page 48: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/48.jpg)
![Page 49: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/49.jpg)
![Page 50: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/50.jpg)
Horizontal trabeculae are important for bone strength: Eular Buckling Theory
Structure 1 is 16x stronger than Structure 2
Assume: Volume 1 = Volume 2Identical Material and dimensions for both
Structure 1 Structure 2
![Page 51: Osteoporosis 2016 | What are the properties of the perfect therapy? Prof. Jon Tobias #osteo2016](https://reader035.fdocuments.in/reader035/viewer/2022062503/5871f3b31a28ab5c348b60b5/html5/thumbnails/51.jpg)
Osteoporosis affects both trabecular and cortical bone
Cortical bone:•85% of bone•EndoskeletonTrabecular
bone:•15% of bone•Endoskeleton•Calcium reservoir•Haematopoeisis